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Abstract: The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency 
to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by 
using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to 
create clots. The Thrombo-Monitor observes the very initial changes of blood viscosity, which 
occurs due to the temporarily induced stasis of capillary blood of the finger. One hundred and 
fifteen patients aged .65 years (matched by age and sex) participated in the study. Patients were 
initially divided into four groups based on the patient’s medical therapy. The study groups were: 
warfarin, enoxaparin, aspirin and/or clopidogrel, and a control group. The medications were 
given according to the patient’s comorbidities (eg, atrial fibrillation [AF], status post pulmonary 
embolism [S/p PE], status post cerebrovascular accident [S/p CVA]). The Thrombo-Monitor 
Index (TMI) is a noninvasive index, derived on the basis of laboratory test results of interna-
tional normalized ratio (INR) and prothrombin time (PT) values. For the group of patients who 
were treated only with warfarin, TMI was adjusted by using the jackknife statistical approach to 
create maximum correlation and linearity with INR and PT values that ranged from 1.1 to 5.0. 
For all warfarin patients (N = 35) the TMI was found to have a good correlation with INR and 
PT values (R2 = 0.64, P , 0.00001); mean TMI = 1.86 (SD = 0.91); mean INR and PT = 2.3 
(SD = 0.91). The calibration curve thus generated was used to calculate the TMI for all other 
groups: aspirin group, mean TMI = 1.3 (SD = 0.14, N = 23), corresponding approximately to 
INR and PT values of 1.036; enoxaparin group (N = 24), mean TMI = 1.34 (SD = 0.304), cor-
responding to mean INR and PT values of 1.07 (SD = 0.3); control group, INR and PT $ 1 
(N = 32), mean TMI = 1.24 (SD = 0.32). R2 of all control and warfarin patients (N = 67) was 
0.55 (P , 0.00001). In summary, the newly introduced TMI index is significantly correlated 
with INR and PT values.
Keywords: anticoagulant monitoring, elderly, noninvasive coagulability index, noninvasive 
measurement
Introduction
The use of international normalized ratio (INR) and prothrombin time (PT) labora-
tory tests is widespread in geriatric practice. However, the consistent use of these tests 
leads to physical inconvenience for the patient, especially in the elderly. Therefore, 
the development of a noninvasive device for the measurement of INR and PT values, 
as well as other blood tests, would be groundbreaking for practical daily medicine, 
particularly with geriatric patients. Apart from yielding immediate results, the non-
invasive measurement of blood coagulability parameters will reduce the pain, the 
inconvenience, and the risk of infection associated with obtaining the patient’s blood 
sample for analysis.Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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Near infrared (NIR) spectroscopy has become a popular 
technology in the biomedical field, in particular in noninva-
sive pulse oximeters.¹ Elfi-Tech’s (Elfi-Tech Ltd, Rehovot, 
Israel) noninvasive approach is based on a similar technology. 
The new device, the Thrombo-Monitor (model ELFI-3), uses 
the principles of NIR dynamic light scattering to measure 
changes in the blood plasma viscosity caused by the stage 
of the local blood stasis of capillary blood of the finger. It 
monitors the tendency of blood to create clots by observing 
the very initial changes of blood viscosity, due to the tem-
porarily induced stasis. In order to create the blood stasis 
condition, over-systolic pressure is applied in the vicinity of 
the measurement site, commonly a finger.² This procedure 
resembles a manipulation that is commonly used for blood 
pressure measurement.
Experimental
Patient selection
One hundred and fifteen consecutive patients $65 years of 
age participated in the study. All were hospitalized in the 
Geriatric Department for rehabilitation after a stroke, ortho-
pedic surgery (hip fractures, hip, or knee replacements), or 
deconditioning after severe illness requiring long hospital-
ization. They included 74 females (age range: 67–98 years) 
and 48 males (age range: 68–97 years).
Patients were initially divided into four groups based on 
the current medical treatment of the patient: warfarin, enox-
aparin, aspirin/clopidogrel, and a control group, and were 
matched for age and sex. The reasons for anticoagulation 
therapy were: atrial fibrillation, pulmonary embolism, and 
prevention of deep vein thrombosis postorthopedic surgery 
such as total knee replacement. Anti-aggregation therapy was 
prescribed for patients suffering from ischemic heart disease 
(IHD), s/p ischemic stroke, and so on.
Patient statistics
Thirty-five patients received warfarin (2.5–7.5 mg/day); 24 
received enoxaparin (60–120 mg/day); 18 received aspirin 
(75–100 mg/day); four received clopidogrel (75 mg/day); 
and two received aspirin and clopidogrel; 32 control patients 
received other drugs, which are not specified as blood thin-
ning. Seven patients who were treated with both anticoagu-
lation and anti-aggregation therapy were excluded from the 
study: three patients aspirin and enoxaparin; two patients 
aspirin and warfarin; one patient warfarin and clopidogrel; 
one patient clopidogrel and enoxaparin.
noninvasive device
The Thrombo-Monitor is completely noninvasive (see appendix 
for the physics principles of the device).
The sensor probe is placed on the fingernail bed. The 
probe consists of two elements: an illuminating and stimulat-
ing NIR light source–coherent light source (low power laser 
diodes), illuminating the skin, and a photo-detector collecting 
the scattered light from the object (Figure 1). A sphygmo-
manometer cuff is automatically inflated by the device prior 
to starting the measurement session, in order to change the 
blood flow status at the measurement location area (2). Over-
systolic pressure is applied to the finger for 25 seconds to 
detect the temporary changes in local plasma viscosity. We 
used the maximal pressure in the cuff (240 mmHg), since 
we assumed that this value exceeds the systolic value for all 
patients. The pressure in the cuff is automatically regulated, 
and once an operator pushes the start button, the pneumatic 
inflation of cuffs is automatically initiated and the predefined 
pressure is reached in about 1 second. This pressure is kept 
constant throughout the measurement session. The time-de-
pendent character of these changes is driven by the tendency 
of the blood to coagulate. We performed each measurement 
six times in order to ensure a stable result, and there was a 
single operator during the trial. The device does not require 
any special training.
It should be emphasized that the Thrombo-Monitor Index 
(TMI) methodology does not measure bulk flow viscosity. 
By analyzing the speckle pattern of the reflected light, the 
dynamics of red blood cell (RBC) Brownian movement 
are determined. The speckle pattern is used to calculate the 
diffusion coefficient of the moving RBCs. This diffusion 
Figure 1 The noninvasive device.Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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coefficient is expressed in terms of the mean free path. 
Formally speaking, this diffusion coefficient is a function of 
the particle size (single RBC) and viscosity of the surround-
ing media (plasma). However, this viscosity is not entirely 
equivalent to the rheological plasma viscosity. All factors 
governing the Brownian movement of RBCs contribute to 
the so-called effective viscosity. Therefore, the optically 
measured movement pattern of the RBC can be expressed 
in terms of the effective viscosity. It is very likely that one 
of the most significant effects on RBC movement in the 
capillary vessels is an interaction between the RBCs and 
the vessel walls. Actually, in endothelial cells, flow-induced 
shear stress stimulates numerous responses. In an extreme 
case of zero shear stress, stationary RBCs induce a nega-
tive charge on mucosal capillary endothelium. In addition, 
under hypoxia, which is induced during the stasis stage, 
the endothelial cells are submitted to high levels of stress, 
resulting in changes of charge. It is clear that electrical 
forces significantly change the movement of the RBCs in 
close vicinity to the endothelial surface. Therefore, RBC 
movement depends on endothelium, fibrinogen, and other 
factors affecting the hemostasis. All these factors being 
taken together can be expressed in terms of effective plasma 
viscosity.
Methods
Blood was drawn from the patients for measurement of INR 
and PT values, using routine laboratory test procedures 
(Sysmex Lab). Within 1 hour after this procedure, the same 
patients were monitored using the noninvasive device. The 
results of both tests were then compared.
statistical analysis
The jackknife statistical approach was applied for data 
analysis.³ This well-known resampling-based method 
assesses standard error, correlation, and bias for relatively 
small data sets. Each point of the calculated data set was 
obtained by leaving out one observation from the original 
data set. The original data set, excluding one point, was 
used for the calibration. Based on this calibration, accord-
ing to laboratory INR and PT values data, the noninvasive 
equivalent TMI index was calculated for the excluded data 
point. This procedure was repeated for all data points. By 
using this approach all data points were included for further 
statistical analysis. This data set consists of both laboratory 
data of INR and PT values and corresponding TMI values. 
These data were further analyzed for standard deviation (SD) 
and   correlation coefficient based on one-factor ANOVA 
analysis.
Results
A new noninvasive index, TMI, was used. This index was 
derived from lab test values of INR and PT for the warfarin-
only group of patients. This index was adjusted by using the 
jackknife’s statistical approach³ to create maximum correla-
tion and linearity with INR and PT values, which ranged from 
1.1 to 5.0. The results were plotted as a calibration curve 
(Figure 2). For all warfarin patients (N = 35), TMI was found 
to be strongly correlated with INR and PT values (R2 = 0.64, 
P , 0.00001); mean TMI = 1.86 (SD = 0.91), and mean INR 
and PT = 2.3 (SD = 0.91).
In the second stage of the analysis, the TMI was cal-
culated for all other groups, based on calibration with the 
warfarin group. For the aspirin patients, mean TMI was 1.3 
(SD = 0.14, N = 23), including patients administered aspirin 
and other drugs (except warfarin). This TMI value corre-
sponds approximately to INR and PT values of 1.036.
For the enoxaparin group (N = 24) mean TMI was 1.34 
(SD = 0.304), corresponding to mean INR and PT values of 
1.07 (SD = 0.3). For the control patient subgroup with INR 
and PT values $ 1 (N = 32) mean TMI was 1.24 (SD = 0.32). 
The R2 of all control and warfarin patients (N = 68) was 0.55 
(P , 0.00001).
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Figure 2 calculated calibration curve for the warfarin-only patient group (n = 35): 
TMi  (Thrombo-Monitor  index)  vs  international  normalized  ratio  (inr)  and 
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Discussion
The feasibility of the noninvasive assessment of blood 
coagulability has been tested by using a novel device, the 
Thrombo-Monitor. The rationale for this technique is as 
follows. It is assumed that during the stasis session, and 
for up to 25 seconds, at least two elements of Virchow’s 
triad are activated in the area located under the pressurizing 
cuff.4 Thus, the first element of the Virchow’s triad, namely 
local blood flow disturbance (entire blood flow cessation) is 
achieved. Second, blood vessel walls are stressed under the 
applied pressure. This is another of Virchow’s elements. The 
blood flow and blood pressure regulate endothelial-related 
vascular reactivity and confine platelet adhesion and aggrega-
tion, as well as fibrin formation, to sites of endothelial injury. 
Thus, the very initial pre-conditions to start the blood clotting 
process are met. As a direct result of the activation of the clot-
ting process, the steady state equilibrium is disturbed and the 
plasma viscosity gradually increases. The time-dependence 
of the above-mentioned biochemical and physical parameters 
is actually the rate of thrombus formation.
A NIR reflection measurement technique enables detec-
tion of these time-dependent changes. The calculated char-
acteristic is the so-called ACF (autocorrelation function). 
This characteristic is normalized and dependent on the 
intensity of the light. So any attenuation factors of skin and 
tissue, depth of penetration, and other local characteristics 
does not affect the ACF. The ACF depends only on the 
single scattering characteristics of the red blood cells and 
their movement pattern. Following analysis of our data by 
conventional statistical techniques, the correlation obtained 
with INR and PT values for the group of warfarin patients is 
excellent and although there is also a remarkable sensitivity 
to one other anticoagulant and one anti-aggregation drug, 
namely enoxaparin and aspirin, further investigation needs to 
be performed to prove its accuracy in these tests. However, 
the Thrombo-Monitor seems a promising tool to reflect the 
general status of coagulability.
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Appendix
system description and physics
The TMI system consists of the data acquisition probe, 
processing system, and display. The probe unit includes the 
diode laser, the pressurizing assembly, detector, and ampli-
fier. The cuff can be controlled by the processing unit. The 
measurement process starts when, by means of a pneumatic 
cuff, over-systolic pressure is applied and blood flow ces-
sation for 20 seconds is set. The over-systolic pressure is 
applied in the vicinity of the measurement location such 
that blood perturbation or stasis is induced. This action is 
facilitated by a pressurizing cuff, which is located at the fin-
ger root. This cuff provides local squeezing of the arterioles 
resulting in blood flow cessations at the area of measurement. 
After 20–30 seconds, pressure application is temporarily 
deactivated and free blood flow is allowed. This procedure 
resembles a manipulation which is commonly used for blood 
pressure measurement. During the stasis session, lasting up 
to 30 seconds, at least two elements of Virchow’s triad are 
activated at the area located under the pressurizing cuff. 
In terms of Virchow’s triad, local blood flow disturbances 
entire blood flow cessation is induced achieved. This is 
the first element of Virchow’s triad. Second, blood vessels 
walls are stressed under the applied pressure. This is another 
  Virchow’s element. This blood flow and blood pressure 
regulates endothelial-related vascular reactivity and confines 
platelet adhesion and aggregation as well as fibrin formation 
to sites of endothelial injury. The secretion and release of 
endothelial defenses such as nitric oxide (NO), prostacy-
clin (PGI2), and tissue plasminogen activator (t-PA) are 
shear-dependent. In addition, the oxygen supply deficiency 
leads to the pre-ischemic conditions which may trigger the 
endothelium to start releasing pro-clotting proteins and to 
stop releasing some others.
Once blood flow cessation is established, a process of 
RBC aggregation evolves which induces another change in 
blood conditions. Therefore, at least two Virchow’s triad 
elements are activated, namely, blood vessel wall stress and 
abnormality of blood flow stasis. Thus, the very initial pre-
conditions to start blood hemostasis process are met. As a 
direct result of activation of a clotting process, the effective 
plasma viscosity increases.
The physical background
When a coherent source of light having a known frequency 
is directed at the moving particles, the light is scattered, but 
at a different frequency. The shift is termed a Doppler shift 
or broadening, and the concept is the same for light when it 
interacts with small moving particles. For the purposes of 
particle measurement, the shift in light frequency is related 
to the relative movement of the particles causing the shift. 
The DLS technique is widely used to measure hydrodynamic 
sizes, polydispersities, and aggregation effects of protein 
samples. Actually, DLS measures the translational diffusion 
of particles due to Brownian motion; therefore, the DLS mea-
surement of particle size is strongly influenced by viscosity, 
both in the calculation and in how the sample behaves.
In this simple case the movement of RBC is expressed 
in terms of the mean free path 〈∆r2(τ)〉,
This parameter can be expressed by:
  ∆rD D
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where T is the temperature of plasma, KB the Boltzmann con-
stant, DB diffusion coefficient, η is viscosity of the plasma, 
and d is the size of the particle.
The DLS technique enables evaluation of the mean free 
path of the moving particle by studying the time-dependent 
pattern of the scattered light. By knowing the mean free path 
and by using the viscosity of the surrounding media, particle 
size can be evaluated.
In the experiments the following quantity is conveniently 
measured:
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where I is the intensity of measured optical signal.
In case of the single scattering from the uncorrelated 
Brownian particles we have:
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A is dependent on the geometry and the mean light inten-
sity and q is defined by:
  q =
4
2
π
λ
θ sin( /)  
λ0- is the wavelength in the vacuum, n is the   refractive 
index of the surrounding medium, and θ is the angle between 
the incident light and the detection axis. In our further esti-
mations, we took n = 1.33, T = 310K, η = 0.015 Psec (for 
37°C)
So the diffusion coefficient DB can be determined by using 
optical measurement.Journal of Blood Medicine
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